VJHemOnc Podcast cover image

T-cell lymphoma highlights at ASH 2022: unmet needs, clinical trial updates & future outlooks

VJHemOnc Podcast

00:00

Investigating C-Net Relapse and New Strategies for Treating T-cell Lymphoma

This chapter discusses the data about C-net relapse in T-cell lymphoma, including risk factors, incidence, and challenges of treatment. It also mentions studies on drugs like R2, laminar, azacitidine, and romidepsin, and highlights the potential of targeted trials for specific entities in T-cell lymphoma.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app